3,4-methylenedioxyamphetamine has been researched along with Autoimmune Diabetes in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fallon, A | 1 |
| Dunne, F | 1 |
| Neithercott, T | 1 |
1 review available for 3,4-methylenedioxyamphetamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Breastfeeding practices that support women with diabetes to breastfeed.
Topics: Breast Feeding; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; | 2015 |
1 other study available for 3,4-methylenedioxyamphetamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Dating game. How to involve your significant other in your significant disease.
Topics: Communication; Diabetes Mellitus, Type 1; Female; Humans; Interpersonal Relations; Love; Male; Socia | 2012 |